NCT06212388 2024-01-25
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
Xijing Hospital
Phase EARLY_PHASE1 Not yet recruiting
Xijing Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano